Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 25, 1998

View Archived Issues

Novel use proposed for EGCg: inhibition of HIV-1

ICAAC news flash: Lilly presents phase I results for glycopeptide antibiotic

SB and LG Chemical profile their broad-spectrum fluoroquinolone at ICAAC

New gastric prokinetic agents in the Zeria pipeline

Kissei discovers series of vascular smooth muscle cell proliferation inhibitors

Warner-Lambert team prepares inhibitors of bacterial signal transduction

Broad-spectrum antiviral agents related to phosphonoformic acid patented by Astra

Novel cephems from Meiji Seika active against resistant bacterial strains

Organon designs nonpeptide thrombin inhibitors mimicking D-Phe-Pro-Arg

ZK-200775: a water-soluble AMPA antagonist with an excellent pharmacological profile

Negative results reported for ImmuCell's TravelGAM; development focus now on DiffGAM

HSR-903 shows excellent antibacterial activity, intracellular penetration in in vitro studies

Acquisition of Hexagen by Incyte completed

Clinical results support use of nesiritide over dobutamine in acute CHF

Head-to-head comparison of two HBV vaccines

KRM-1648 combinations show strong, rapid and long-lasting antimycobacterial activity

Administration of multiple high doses of S-4661 does not affect safety, pharmacokinetics

IB-643 more effective than AmB in treating systemic murine candidosis

Profile of activity of new antifungal antibiotic presented by Fujisawa at ICAAC

Oxigene updates Neu-Sensamide development status

Vanguard discontinues development of psoriasis drugs

HMR grants Matrix rights to anticancer agent about to enter phase II

Astra returns rights to ALX1-11; Allelix to aggressively pursue development

In vitro and in vivo activity of S-34109 against Chlamydia and MRSA

Zanamivir results presented at ICAAC; two more regulatory filings announced

Investigational anti-HIV drug offered through early access program

P&U explores modifications to linezolid; new, more active oxazolidinones result

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...